Here’s the Press Release / Abstract

More at https://www.ameriresearch.com/product/legal-marijuana-market-outlook-2024-depth-market-view-key-categories-recreational-medical-application-pain-management-arthritis-cancer-multiple-sclerosis-alzheimers-regio/

The global legal marijuana market was valued at $14.3 bn in 2016 and is forecast to grow at a CAGR of 21.1% between 2017 and 2024, culminating in 2024 global sales of $63.5bn.

The legal marijuana market is witnessing robust growth owing to the increasing legalization and decriminalization of marijuana across North America and Europe. The rising demand of marijuana for recreational use and medical use is a key factor driving the growth. Due to the complex regulatory structure at state level and federal level, the full potential of the market is not yet realized.

 

In the U.S., 44 states have different cannabis laws however, cannabis is illegal as per federal law. The U.S. federal law regulates cannabis as per the Controlled Substances Act (CSA), and this act does not differentiate between recreational and medical cannabis. The CSA classifies marijuana as a Schedule I drug which under federal views is highly addictive with no medical value.

 

However, as per the 2016 funding bill for Commerce-Justice-Science (CJS) budgets, the U.S. federal government is prohibited to use the justice department funds in preventing the states implementing their medical marijuana laws. Moreover, as per the Rohrabacher-Farr or CJS amendment which was previously signed into law on December 16th,2014, and re-signed on December 18th, 2015, prohibits the federal agencies from raiding, arresting, prosecutions for cannabis use. In different states.